A recent MIT study demonstrates that different mutations within the MECP2 gene, which causes Rett syndrome, result in distinct neurological abnormalities and require targeted, mutation-specific treatments rather than a universal therapeutic approach.
#Neuroscience #Genetics #MolecularBiology #Pharmaceutical #sflorghttps://www.sflorg.com/2026/05/ns05042602.html